The present application relates to novel 6.alpha.-fluoro prednisolone 17, 21-diesters, to pharmaceutical compositions comprising such diesters, and to methods of treating inflammatory conditions with such diesters.
6-Alpha-fluoro-16-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them
申请人:STEROSYNT Ltd.
公开号:EP0029924A1
公开(公告)日:1981-06-10
Novel 6α-fluoro-, 6a-fluoro-16a-methyl- and 6a-fluoro-16β-methyl-prednisolone 17,21-diesters, and a method for their preparation, are described. The novel products are particularly valuable as anti-inflammatory agents.